IL-37 inhibits M1-like macrophage activation to ameliorate temporomandibular joint inflammation through the NLRP3 pathway.

MLA

Luo, Ping, et al. “IL-37 Inhibits M1-like Macrophage Activation to Ameliorate Temporomandibular Joint Inflammation through the NLRP3 Pathway.” Rheumatology, vol. 59, no. 10, Oct. 2020, pp. 3070–80. EBSCOhost, https://doi.org/10.1093/rheumatology/keaa192.

APA

Luo, P., Peng, S., Yan, Y., Ji, P., & Xu, J. (2020). IL-37 inhibits M1-like macrophage activation to ameliorate temporomandibular joint inflammation through the NLRP3 pathway. Rheumatology, 59(10), 3070–3080. https://doi.org/10.1093/rheumatology/keaa192

Chicago

Luo, Ping, Sisi Peng, Yin Yan, Ping Ji, and Jie Xu. 2020. “IL-37 Inhibits M1-like Macrophage Activation to Ameliorate Temporomandibular Joint Inflammation through the NLRP3 Pathway.” Rheumatology 59 (10): 3070–80. doi:10.1093/rheumatology/keaa192.